Kintara Therapeutics Announces Adjournment of Special Meeting of Stockholders until October 4, 2024

Provided By PR Newswire

Last update: Sep 20, 2024

SAN DIEGO, Sept. 20, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced it adjourned the Special Meeting of Stockholders (the "Special Meeting") held on September 20, 2024. The Special Meeting will reconvene on October 4, 2024 at 9:00 a.m., Eastern Time at www.viewproxy.com/kintarasm/2024.